The Impact of Tumor Microenvironmental Acidity on Bicalutamide Sensitivity in Prostate Cancer Cells
Prostate Cancer · 2026-01 · 2026 (1)
DOI: 10.1155/proc/4321914 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prostate Cancer, online erschienen am 05.04.2026. Verfasst von Pedram Golmohammadi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran, tums.ac.ir. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Prostate cancer is the second most commonly diagnosed cancer worldwide. Although androgen deprivation therapy initially demonstrates clinical benefit, disease relapse with more aggressive phenotypes frequently occurs. The acidic tumor microenvironment in solid tumors may alter drug responsiveness. This study investigates how extracellular pH influences the cytotoxic effects of bicalutamide in human prostate cancer cell lines.
Methods
PC3 and LNCaP cells were exposed to bicalutamide at varying concentrations at pH 7.4 and pH 6.8. IC50 values were determined using the MTT assay. Cell migration, apoptosis, and cell cycle distribution were evaluated by wound‐healing assay, annexin V/PI staining, and DNA content analysis, respectively. The expression of BAX , BCL2 , E-cadherin , N-cadherin , SNAI1 , AR , and VEGF-C was quantified by qPCR.
Results
Bicalutamide (140 μg/mL) reduced PC3 cell viability to 39.62% at pH 7.4 compared with 51.36% at pH 6.8. In LNCaP cells, viability declined to 33.64% at pH 7.4% and 56.09% at pH 6.8. Treated PC3 cells exhibited significantly greater migration at pH 6.8 ( p < 0.01). Early apoptosis in treated LNCaP cells was significantly reduced at pH 6.8 ( p < 0.001). Both cell lines demonstrated enhanced S phase accumulation and reduced G1‐phase distribution at pH 6.8. The BAX / BCL2 ratio was significantly decreased at pH 6.8, indicating the suppression of proapoptotic signaling. Additionally, genes associated with epithelial–mesenchymal transition (EMT) were upregulated, and VEGF-C and AR expression increased at pH 6.8 ( p < 0.05).
Conclusion
The efficacy of bicalutamide in prostate cancer cells is significantly influenced by extracellular pH. The drug exerts stronger cytotoxic, antimigratory, and proapoptotic effects at physiological pH (7.4) compared with acidic conditions (6.8).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran, tums.ac.ir.
- Department of Urology, Yale School of Medicine, New Haven, Connecticut, USA, yale.edu.
ORCID-Profile: Pedram Golmohammadi, Iman Menbari Oskouie, Rahil Mashhadi, Seyed Mohammad Kazem Aghamir
Zitieren
APA
Golmohammadi, P., Haghani, I., Menbari Oskouie, I., Mashhadi, R., Rezaeian, A., & Aghamir, S. M. K. (2026). The Impact of Tumor Microenvironmental Acidity on Bicalutamide Sensitivity in Prostate Cancer Cells. Prostate Cancer, 2026(1). https://doi.org/10.1155/proc/4321914
Vancouver
Golmohammadi P, Haghani I, Menbari Oskouie I, Mashhadi R, Rezaeian A, Aghamir SMK. The Impact of Tumor Microenvironmental Acidity on Bicalutamide Sensitivity in Prostate Cancer Cells. Prostate Cancer. 2026;2026(1). doi:10.1155/proc/4321914
BibTeX
@article{Golmohammadi2026,
author = {Golmohammadi, Pedram and Haghani, Idris and Menbari Oskouie, Iman and Mashhadi, Rahil and Rezaeian, Ahmadreza and Aghamir, Seyed Mohammad Kazem},
title = {The Impact of Tumor Microenvironmental Acidity on Bicalutamide Sensitivity in Prostate Cancer Cells},
journal = {Prostate Cancer},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/proc/4321914}
}
EUVIMED